Dec 31, 2025 • Business Wire
BEARISH
INSP INVESTORS: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of Inspire Medical Systems, Inc.
Kirby McInerney LLP reminds investors of Inspire Medical Systems, Inc. (NYSE:INSP) about the January 5, 2026 deadline to seek lead plaintiff status in a class action lawsuit. The lawsuit alleges that Inspire Medical Systems made false or misleading statements regarding the poor demand and problematic launch of its Inspire V medical device, leading to a significant stock price drop. Investors who acquired Inspire securities between August 6, 2024, and August 4, 2025, and suffered losses are encouraged to contact the firm.
Dec 30, 2025 • GlobeNewswire
BEARISH
Deadline Alert: Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Glancy Prongay & Murray LLP is alerting shareholders of Inspire Medical Systems, Inc. (INSP) to a securities fraud lawsuit deadline on January 5, 2026. The lawsuit claims that Inspire made misleading statements between August 6, 2024, and August 4, 2025, concerning issues with its new Inspire V sleep apnea device launch, leading to a significant stock price drop. Investors who suffered losses are encouraged to contact the firm to inquire about potentially recovering their losses.
Dec 30, 2025 • ACCESS Newswire
BEARISH
Inspire Medical Systems, Inc. (INSP) Shareholders Get Answers in Latest SueWallSt Podcast
Levi & Korsinsky, LLP has released a podcast addressing a class action securities lawsuit filed on behalf of Inspire Medical Systems, Inc. (NYSE:INSP) investors. The lawsuit alleges securities fraud between August 6, 2024, and August 4, 2025, claiming the company made false statements and concealed issues regarding the unsuccessful launch of its new product, Inspire V. The firm encourages shareholders who have suffered losses to contact them for more information.
Dec 30, 2025 • KRON4
BEARISH
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm is reminding investors of a class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP) for alleged securities fraud violations between August 6, 2024, and August 4, 2025. The lawsuit claims that Inspire made misleading statements about the launch of its Inspire V device, which reportedly had weak demand and was poorly managed. Investors who suffered losses are encouraged to contact the firm by January 5, 2026, to participate in the lawsuit.
Dec 29, 2025 • GlobeNewswire
BEARISH
Bronstein, Gewirtz & Grossman LLC Urges Inspire Medical Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP) and its officers. The lawsuit seeks to recover damages for investors who purchased Inspire securities between August 6, 2024, and August 4, 2025, alleging the company made materially false and misleading statements about the demand and launch readiness of Inspire V. Investors have until January 5, 2026, to request to be appointed as lead plaintiff.
Dec 29, 2025 • KRON4
BEARISH
Inspire Medical Systems, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INSP
DJS Law Group is reminding investors of a class-action lawsuit against Inspire Medical Systems, Inc. (INSP) for alleged securities law violations. The lawsuit claims Inspire made false and misleading statements regarding the launch of its Inspire V therapy system, which was met with weak demand despite company claims of high market demand. Shareholders who purchased INSP shares between August 6, 2024, and August 4, 2025, are encouraged to contact DJS Law Group to discuss their rights and potential lead plaintiff appointments, with a deadline of January 5, 2026.